Overall, these findings suggest that the relationship between MYCN amplification, TCI, and mesenchymal cell lineage is complex and interwoven and increased understanding of these relationships is vital to understanding the immune component of neuroblastoma. The gene discussed is MYCN; the disease is neuroblastoma.